Fieldpoint Private Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.67M Buy
5,152
+2,592
+101% +$778K 0.48% 49
2022
Q1
$733K Buy
2,560
+43
+2% +$11.1K 0.15% 161
2021
Q4
$695K Buy
2,517
+135
+6% +$34.2K 0.14% 172
2021
Q3
$550K Sell
2,382
-19
-0.8% -$4.69K 0.12% 187
2021
Q2
$647K Buy
2,401
+282
+13% +$56.6K 0.14% 171
2021
Q1
$396K Sell
2,119
-303
-13% -$59.3K 0.09% 220
2020
Q4
$409K Buy
2,422
+548
+29% +$81.8K 0.09% 213
2020
Q3
$277K Buy
1,874
+150
+9% +$23.2K 0.08% 236
2020
Q2
$283K Buy
1,724
+168
+11% +$25.8K 0.1% 197
2020
Q1
$216K Buy
1,556
+56
+4% +$7.69K 0.08% 221
2019
Q4
$197K Sell
1,500
-165
-10% -$19.1K 0.06% 265
2019
Q3
$186K Sell
1,665
-68
-4% -$7.57K 0.07% 219
2019
Q2
$192K Buy
1,733
+430
+33% +$50.6K 0.06% 236
2019
Q1
$169K Hold
1,303
0.07% 208
2018
Q4
$151K Hold
1,303
0.07% 210
2018
Q3
$140K Sell
1,303
-20
-2% -$2K 0.05% 235
2018
Q2
$113K Hold
1,323
0.04% 248
2018
Q1
$102K Sell
1,323
-165
-11% -$13.3K 0.05% 237
2017
Q4
$126K Sell
1,488
-225
-13% -$19.1K 0.07% 207
2017
Q3
$147K Buy
+1,713
New +$140K 0.06% 223
2017
Q2
Sell
-1,398
Closed -$118K 278
2017
Q1
$118K Buy
+1,398
New +$112K 0.09% 133

Other funds holding LLY

Fieldpoint Private Securities's LLY Position: Q2 2022 in Review

Fieldpoint Private Securities increased its Eli Lilly (LLY) stake by 101% in Q2 2022, buying an estimated $778K and bringing the position to 5,152 shares worth $1.67M. The position accounts for 0.48% of the portfolio, ranked #49.

Fieldpoint Private Securities first reported a position in LLY in Q1 2017 and has held it in 21 quarters since. 2,446 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

  • Fieldpoint Private Securities held 5,152 shares of Eli Lilly worth $1.67M as of Q2 2022.
  • Fieldpoint Private Securities bought 2,592 Eli Lilly shares in Q2 2022, an estimated $778K.
  • Eli Lilly made up 0.48% of Fieldpoint Private Securities's portfolio in Q2 2022, its #49 holding.
  • Fieldpoint Private Securities first reported a position in Eli Lilly in Q1 2017 and has held it in 21 quarters since.
  • 2,446 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.